World News

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.

The closure announcement follows Valneva’s financial results for the first nine months of 2025, which revealed mixed performance.

The guidance comes as more than one billion people worldwide currently live with obesity, a number projected to double by 2030 without decisive intervention.

This oral formulation offers a more convenient delivery method compared to intravenous treatments.

Philips has pioneered this detector-based spectral CT approach that produces multiple spectral outputs from a single scan without sacrificing performance or increasing scan time.

AdipoLABs operates as a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), providing regulatory credibility and demonstrating commitment to quality and innovation.

The total USD20.9 million funding will be divided into two tranches, with the release of the second contingent on outcomes from the ongoing ‘SEALS’ phase 2 clinical trial.

Eydenzelt will be available in both pre-filled syringe and vial formats, and it is approved for all the same uses as the original Eylea treatment.

Surgiphor is formulated as a pre-mixed, sterile irrigation solution designed to help clear surgical wounds of debris and foreign materials during procedures, eliminating the need for hospital staff to prepare the solution on-site.

LumiGuide enables physicians to visualize and guide devices inside the body using light instead of continuous X-ray imaging.